Evidence map›Paper›PMID 35301426›Full record

ArticleMolecular psychiatry2022

Chronic stress disrupts the homeostasis and progeny progression of oligodendroglial lineage cells, associating immune oligodendrocytes with prefrontal cortex hypomyelination.

Alexandros G Kokkosis, Miguel M Madeira, Matthew R Mullahy, Stella E Tsirka

Open access · greenAbstract read
In one paragraph

Article in Molecular psychiatry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed, 2 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 61 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Pde4 mediates MHCII expression in oligodendroglia.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Alexandros G KokkosisDepartment of Pharmacological Sciences, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794-8651, USA.ORCID http://orcid.org/0000-0001-5148-3290
Miguel M MadeiraDepartment of Pharmacological Sciences, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794-8651, USA.ORCID http://orcid.org/0000-0001-9771-0727
Matthew R MullahyDepartment of Pharmacological Sciences, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794-8651, USA.
Stella E TsirkaDepartment of Pharmacological Sciences, Renaissance School of Medicine at Stony Brook University, Stony Brook, NY, 11794-8651, USA. styliani-anna.tsirka@stonybrook.edu.ORCID http://orcid.org/0000-0003-0022-1770
Stony Brook School · USRegeneron (United States) · US

Funding

Supplement to Lithium's Molecular Mechanism of Action and the Pathology of Bipolar DisordersR01MH090276 · NIMH · STATE UNIVERSITY NEW YORK STONY BROOK · PI PARSEY, RAMIN V. · 2011 to 2015
$4.2M
A translational study of neuroinflammatory depression: Understanding mechanism and evaluation of a novel pharmacologic intervention - Diversity Administrative supplement for Kimberly NnahR01MH123093 · NIMH · STATE UNIVERSITY NEW YORK STONY BROOK · PI DELORENZO, CHRISTINE, PARSEY, RAMIN V. · 2020 to 2024
$3.8M
Biological Predictors of Response to AntidepressantsR01MH074813 · NIMH · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PARSEY, RAMIN V. · 2006 to 2010
$2.3M
Scholars in BioMedical Sciences (SBMS) Training ProgramT32GM127253 · NIGMS · STATE UNIVERSITY NEW YORK STONY BROOK · PI TSIRKA, STYLIANI-ANNA (STELLA) E · 2018 to 2022
$689k
NIGMS NIH HHS T32 GM127253NIMH NIH HHS R01 MH074813NIMH NIH HHS R01 MH090276NIMH NIH HHS R01 MH123093
6 · The paper itself

Abstract

Major depressive disorder (MDD) is a chronic debilitating illness affecting yearly 300 million people worldwide. Oligodendrocyte-lineage cells have emerged as important neuromodulators in synaptic plasticity and crucial components of MDD pathophysiology. Using the repeated social defeat (RSDS) mouse model, we demonstrate that chronic psychosocial stress induces long-lasting losses and transient proliferation of oligodendrocyte-precursor cells (OPCs), aberrant differentiation into oligodendrocytes, and severe hypomyelination in the prefrontal cortex. Exposure to chronic stress results in OPC morphological impairments, excessive oxidative stress, and oligodendroglial apoptosis, implicating integrative-stress responses in depression. Analysis of single-nucleus transcriptomic data from MDD patients revealed oligodendroglial-lineage dysregulation and the presence of immune-oligodendrocytes (Im-OL), a novel population of cells with immune properties and myelination deficits. Im-OL were also identified in mice after RSDS, where oligodendrocyte-lineage cells expressed immune-related markers. Our findings demonstrate cellular and molecular changes in the oligodendroglial lineage in response to chronic stress and associate hypomyelination with Im-OL emergence during depression.

Indexed as

Major Depressive DisorderMyelin SheathAnimalsCell DifferentiationHomeostasisHumansMiceOligodendrogliaPrefrontal Cortex

Identifiers

PMID35301426
PMCPMC9169792
OpenAlexW4220821106

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.